-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L1BGAUJGUwrIzh1xkoDgKeNoIs71Bs/wzislznGWVQhglBdHdxIM2gIeszZ51x0g 4lbGr0YLCLqzvKOr5GTlTA== 0000940394-96-000301.txt : 19961029 0000940394-96-000301.hdr.sgml : 19961029 ACCESSION NUMBER: 0000940394-96-000301 CONFORMED SUBMISSION TYPE: 24F-2NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960831 FILED AS OF DATE: 19961028 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND INC CENTRAL INDEX KEY: 0000760110 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 521378236 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 24F-2NT SEC ACT: 1933 Act SEC FILE NUMBER: 002-95103 FILM NUMBER: 96648858 BUSINESS ADDRESS: STREET 1: 24 FEDERAL STREET STREET 2: SUITE 4100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 482-8260 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE STREET 2: SUITE 4100 CITY: HOUSTON STATE: TX ZIP: 77057 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL RESEARCH INVESTMENT FUND INC DATE OF NAME CHANGE: 19920703 24F-2NT 1 24F-2 FOR EV TRADITIONAL WW HEALTH @ 8/31/96 October 28, 1996 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 RE: Rule 24f-2 Notice for EV Traditional Worldwide Health Sciences Fund, Inc. (formally Medical Research Investment Fund, Inc.) 1933 Act File No. 2-95103 1940 Act File No. 811-4196 In accordance with the provisions of Rule 24f-2 under the Investment Company Act of 1940, EV Traditional Worldwide Health Sciences Fund, Inc. (formally Medical Research Investment Fund, Inc.) hereby files its Rule 24f-2 Notice for the fiscal year ended August 31, 1996 ("Fiscal Year"). No shares of the Trust which have been registered under the Securities Act of 1933 (other than pursuant to Rule 24f-2) remained unsold at the beginning of the Fiscal Year. No shares of the Trust were registered during the Fiscal Year pursuant to Rule 24e-2. 5,439,762 shares of the Trust, with an aggregate sales price of $68,676,368, were sold during the Fiscal Year in reliance upon the Declaration of the Trust pursuant to Rule 24f-2 which registered an indefinite amount of securities. Attached to this Rule 24f-2 Notice, and made part hereof, is an opinion of counsel indicating that the securities, the registration of which the Notice makes definite in number, were legally issued, fully paid, and non- assessable by the Trust. 236,367 shares of the Trust, with an aggregate sales price of $2,491,303, were issued during the Fiscal Year in connection with the Trust's dividend reinvestment plan. For the Fiscal Year, the Trust sold an aggregate of 5,676,129 shares, including those issued pursuant to its dividend reinvestment plan, with an aggregate sales price of $71,167,671. In accordance with subsection (c) of Rule 24f-2, $9,565.05 has been wired to the SEC Account at Mellon Bank, which represents the registration fee. Such fee is based upon the actual aggregate sale price for which such securities were sold during the Fiscal Year, including dividend reinvestments, reduced by the actual aggregate redemption price of the shares redeemed by the Trust during the Fiscal Year. Rule 24f-2 Notice for Page 2 EV Traditional Worldwide Health Sciences Fund, Inc. (formally Medical Research Investment Fund, Inc.) 1933 Act File No. 2-95103 1940 Act File no. 811-4196 Aggregate Sale Price for Shares Sold During Fiscal Year Pursuant to Rule 24f-2 $ 68,676,368 Aggregate Price of Shares Issued During Fiscal Year In Connection with Dividend Reinvestment Plan 2,491,303 Aggregate Price of Shares Sold $ 71,167,671 Reduced by the Difference Between (1) Aggregate Redemption Price of Shares Redeemed During the Fiscal Period 39,602,995 and (2) Aggregate Redemption Price of Redeemed Shares Previously Applied by Trust Pursuant to Rule 24e-2(a) in Filings Made Pursuant to Section 24(e)(1) of Investment Company Act of 1940 0 Equals $ 31,564,676 Any questions regarding the matter should by addressed to Jim Thebado, Eaton Vance Management, 24 Federal Street, Boston, Massachusetts 02110. Sincerely, James L. O'Connor Treasurer October 28, 1996 OPINION OF COUNSEL Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 RE: Rule 24f-2 Notice for EV Traditional Worldwide Health Sciences Fund, Inc. (formally Medical Research Investment Fund, Inc.) 1933 Act File No. 2-95103 1940 Act File No. 811-4196 Gentlemen: By the filing of the captioned Notice pursuant to Rule 24f-2 under the Investment Company Act of 1940, as amended, the Trust made definite the registration under the Securities Act of 1933 of 5,676,129 shares sold, including those pursuant to its dividend reinvestment plan, in reliance upon said Rule 24f-2 during the fiscal year ended August 31, 1996. It is the opinion of the undersigned that such shares were legally issued, fully paid and nonassessable. Sincerely, H. Day Brigham, Jr. Vice President and Chairman of the Executive Committee Member of Massachusetts and New York Bars -----END PRIVACY-ENHANCED MESSAGE-----